SOLIGENIX INC (SNGX)
US8342235053 - Common Stock
Soligenix to Present at Upcoming Conferences
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Which stocks are moving after the closing bell on Tuesday?
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
On Thursday, there are stocks with unusual volume. Let's take a look.
Which stocks have an unusual volume on Thursday?
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Curious about the stocks that are showing activity before the opening bell on Thursday?
Which stocks are moving before the opening bell on Thursday?
Soligenix Announces Pricing of $4.75 Million Public Offering
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning!
Top movers in Wednesday's after hours session
Get insights into the top gainers and losers of Wednesday's after-hours session.
Unusual volume stocks in Tuesday's session
Unusual volume stocks in Tuesday's session
Why Is Penny Stock Soligenix Trading Higher On Monday?
On Monday, Soligenix Inc (NASDAQ:SNGX) received an FDA orphan drug designation for the active ingredient in MarVax, the subunit protein vaccine of recombinantly expressed Marburg marburgvirus (MARV) glycoprotein, for the prevention and post-exposure prophylaxis against MARV infection. In addition to providing a seven-year term of market exclusivity upon final FDA approval, orphan drug designation also positions Soligenix to be able to leverage a wide range of financial and regulatory benefits, i
Why Are Stocks Up Today?
Stocks are up today and investors wondering what's behind that rally have come to the right place as we have the latest news for Monday!
DJT Stock Alert: Trump Media Plunges on Share Sale Panic
Trump Media & Technology stock is falling hard on Monday as investors react to a filing for a secondary offering of DJT shares.
Why Is Marinus Pharmaceuticals (MRNS) Stock Down 79% Today?
Marinus Pharmaceuticals stock is falling on Monday with heavy trading of MRNS shares after posting an update on a Phase 3 trial.
Why Is Soligenix (SNGX) Stock Up 58% Today?
Soligenix stock is up on Monday with heavy trading of SNGX on news of the company getting orphan drug designation from the FDA.
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
SNGX Stock Earnings: Soligenix Beats EPS, Beats Revenue for Q4 2023
SNGX stock results show that Soligenix beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
SNGX Stock Earnings: Soligenix Beats EPS, Beats Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Soligenix (NASDAQ:SNGX) just reported results for the fourth quarter of 2023.So...
Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix Announces Formation of Behçet's Disease Medical Advisory Board
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix to Present at The Microcap Conference
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix files to sell 10.64M shares of common stock, warrants (NASDAQ:SNGX)
Soligenix files prospectus for resale of 10.64M common shares by selling stockholders; note that this is not an offer to sell these securities.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth checking out on Tuesday to catch up on all of the hottest stock market news for this morning!
FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...